Here are samples of stories you can read with your free trial:

PhRMA Outlines Value-Based Policies To Improve Drug Reimbursement
The notion of value-based contracts remains vague, but the drug industry is pushing a raft of policies to make it easier to base drug prices on outcomes. Industry suggestions include overhauling policies on Medicaid best price, drug discounts for public programs, rebates for private middlemen, anti-kickback laws, FDA restrictions on what drug companies may say about products during development and insurance benefit designs.

Source: Administration Likely To Extend Grandmothered Noncompliant Plans
A former advisor to the Trump transition team expects the administration will extend the ability of issuers to sell non-ACA-compliant insurance plans, sometimes referred to as 'grandmothered' plans, that would otherwise be phased out after 2017. Anthem is pushing for an extension, and America's Health Insurance Plans spokesperson says the lobby does not oppose an extension even though President Marilyn Tavenner cited concerns in an interview last week.

White House Sets Up Cross-Agency Battle To Pay For New Regulations
The White House told federal agencies Friday (Feb. 3) that when they issue a new rule they can request cost-saving offsets from a separate agency, a move a source tells Inside Health Policy could set up cross-agency battles that would be brokered by the White House budget office. The new interim guidance issued by the White House budget office also clarifies that the president's regulatory freeze does not cover Medicare beneficiary spending, excludes federal regulations with deregulatory affect, covers only economically significant regulatory action, and affects significant guidance documents on a case-by-case basis.